IRIS Accounts Production v24.3.0.553 11624351 Board of Directors 1.4.23 31.5.24 31.5.24 0 0 false true false false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh116243512023-03-31116243512024-05-31116243512023-04-012024-05-31116243512022-03-31116243512022-04-012023-03-31116243512023-03-3111624351ns15:EnglandWales2023-04-012024-05-3111624351ns14:PoundSterling2023-04-012024-05-3111624351ns10:Director12023-04-012024-05-3111624351ns10:PrivateLimitedCompanyLtd2023-04-012024-05-3111624351ns10:SmallEntities2023-04-012024-05-3111624351ns10:AuditExempt-NoAccountantsReport2023-04-012024-05-3111624351ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-05-3111624351ns10:SmallCompaniesRegimeForAccounts2023-04-012024-05-3111624351ns10:FullAccounts2023-04-012024-05-311162435112023-04-012024-05-3111624351ns10:OrdinaryShareClass12023-04-012024-05-3111624351ns10:Director22023-04-012024-05-3111624351ns10:RegisteredOffice2023-04-012024-05-3111624351ns5:CurrentFinancialInstruments2024-05-3111624351ns5:CurrentFinancialInstruments2023-03-3111624351ns5:Non-currentFinancialInstruments2024-05-3111624351ns5:Non-currentFinancialInstruments2023-03-3111624351ns5:ShareCapital2024-05-3111624351ns5:ShareCapital2023-03-3111624351ns5:RetainedEarningsAccumulatedLosses2024-05-3111624351ns5:RetainedEarningsAccumulatedLosses2023-03-3111624351ns5:IntangibleAssetsOtherThanGoodwill2023-04-012024-05-3111624351ns5:ComputerSoftware2023-04-012024-05-3111624351ns5:PlantMachinery2023-04-012024-05-3111624351ns5:IntangibleAssetsOtherThanGoodwill2023-03-3111624351ns5:IntangibleAssetsOtherThanGoodwill2024-05-3111624351ns5:IntangibleAssetsOtherThanGoodwill2023-03-3111624351ns5:FurnitureFittings2023-03-3111624351ns5:ComputerEquipment2023-03-3111624351ns5:FurnitureFittings2023-04-012024-05-3111624351ns5:ComputerEquipment2023-04-012024-05-3111624351ns5:FurnitureFittings2024-05-3111624351ns5:ComputerEquipment2024-05-3111624351ns5:FurnitureFittings2023-03-3111624351ns5:ComputerEquipment2023-03-3111624351ns5:WithinOneYearns5:CurrentFinancialInstruments2024-05-3111624351ns5:WithinOneYearns5:CurrentFinancialInstruments2023-03-3111624351ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2024-05-3111624351ns5:BetweenOneTwoYearsns5:Non-currentFinancialInstruments2023-03-3111624351ns10:OrdinaryShareClass12024-05-31
REGISTERED NUMBER: 11624351 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE PERIOD 1 APRIL 2023 TO 31 MAY 2024

FOR

YRHEALTH LTD

YRHEALTH LTD (REGISTERED NUMBER: 11624351)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE PERIOD 1 APRIL 2023 TO 31 MAY 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


YRHEALTH LTD

COMPANY INFORMATION
FOR THE PERIOD 1 APRIL 2023 TO 31 MAY 2024







DIRECTORS: A Goldberg
C I Stone





REGISTERED OFFICE: 4 The Sheepcote Monks Orchard Lumber Lan
Lugwardine
Hereford
HR1 4AG





REGISTERED NUMBER: 11624351 (England and Wales)





ACCOUNTANTS: Cole & Co
4 The Sheepcote
Monks Orchard
Lumber Lane, Lugwardine
Hereford
Herefordshire
HR1 4AG

YRHEALTH LTD (REGISTERED NUMBER: 11624351)

BALANCE SHEET
31 MAY 2024

2024 2023
Notes £    £   
FIXED ASSETS
Intangible assets 4 - 11,769
Tangible assets 5 - 650
- 12,419

CURRENT ASSETS
Stocks 238,046 156,611
Debtors 6 121,605 100,126
Cash at bank 47,800 123,260
407,451 379,997
CREDITORS
Amounts falling due within one year 7 (171,478 ) (246,459 )
NET CURRENT ASSETS 235,973 133,538
TOTAL ASSETS LESS CURRENT LIABILITIES 235,973 145,957

CREDITORS
Amounts falling due after more than one
year

8

(18,203

)

(29,942

)

PROVISIONS FOR LIABILITIES (2,359 ) (2,359 )
NET ASSETS 215,411 113,656

CAPITAL AND RESERVES
Called up share capital 9 2 2
Retained earnings 215,409 113,654
SHAREHOLDERS' FUNDS 215,411 113,656

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 May 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 May 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

YRHEALTH LTD (REGISTERED NUMBER: 11624351)

BALANCE SHEET - continued
31 MAY 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 25 November 2024 and were signed on its behalf by:





C I Stone - Director


YRHEALTH LTD (REGISTERED NUMBER: 11624351)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD 1 APRIL 2023 TO 31 MAY 2024

1. STATUTORY INFORMATION

Yrhealth Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

There have been no material departures from Financial Reporting Standard 102 1A.

TURNOVER
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

INTANGIBLE ASSETS
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Product Website Development is being amortised evenly over its estimated useful life of four years.

TANGIBLE FIXED ASSETS
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on cost

STOCKS
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

FINANCIAL INSTRUMENTS
Basic financial instruments are recognised at amortised cost.

TAXATION
Current tax represents the amount of tax expected to be paid or recovered in respect of taxable profits for the year and is calculated using the tax rates and laws that have been enacted or substantially enacted at the balance sheet date.

DEFERRED TAX
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

YRHEALTH LTD (REGISTERED NUMBER: 11624351)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 1 APRIL 2023 TO 31 MAY 2024

2. ACCOUNTING POLICIES - continued

HIRE PURCHASE AND LEASING COMMITMENTS
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was NIL (2023 - NIL).

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
At 1 April 2023 23,550
Disposals (23,550 )
At 31 May 2024 -
AMORTISATION
At 1 April 2023 11,781
Charge for period 6,721
Eliminated on disposal (18,502 )
At 31 May 2024 -
NET BOOK VALUE
At 31 May 2024 -
At 31 March 2023 11,769

YRHEALTH LTD (REGISTERED NUMBER: 11624351)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 1 APRIL 2023 TO 31 MAY 2024

5. TANGIBLE FIXED ASSETS
Fixtures
and Computer
fittings equipment Totals
£    £    £   
COST
At 1 April 2023 789 747 1,536
Disposals (789 ) (747 ) (1,536 )
At 31 May 2024 - - -
DEPRECIATION
At 1 April 2023 460 426 886
Charge for period 230 218 448
Eliminated on disposal (690 ) (644 ) (1,334 )
At 31 May 2024 - - -
NET BOOK VALUE
At 31 May 2024 - - -
At 31 March 2023 329 321 650

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 118,241 97,885
Prepayments and accrued income 3,364 2,241
121,605 100,126

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts 10,064 9,766
Trade creditors 44,566 45,420
Tax 16,725 24,884
VAT 2,169 12,691
Other creditors 87,164 139,000
Accruals and deferred income 10,790 14,698
171,478 246,459

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
2024 2023
£    £   
Bank loan 18,203 29,942

YRHEALTH LTD (REGISTERED NUMBER: 11624351)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 1 APRIL 2023 TO 31 MAY 2024

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
2 Ordinary £1 2 2